inTRODUCTiOn
ARI for their high incidence and a regular annual occurrence rank are socially, medically and economically the most serious communicabe diseases. ARI are the leading cause of morbidity. Clinically, the most serious illness is influenza.
A notable characteristic of the influenza virus is a high frequency of its antigenic changes. These changes are referred to as antigenic variation. A pandemic, which is always caused by influenza virus A, occurs always following an antigenic shift (1) . A virus, which generates during this shift, has one or both antigens different from the previous virus. In the interpandemic period, the epidemics occur, when only the antigenic drift in the influenza virus occurs. The antigenic drift is generated through the multiply localized changes in the hemagglutinin and neuraminidase gene. However, no exchange of genetic information occurs.
These changes are responsible for annually recurring more or less epidemic (2) .
Because influenza viruses change constantly and epidemics occur annually the need for permanent surveillance of influenza is of prime importance. Regular supervision and organized surveillance is one of the most important methods of controlling the spread of influenza. It focuses on early detection of virus with epidemic or pandemic potential, e.g.early detection and identification of new variants or subtypes of influenza virus circulating in human population. These data then enable the authorities to take immediate and effective measures in preventing and reducing health and social impacts (3) .
The most effective prevention against influenza, from health and economic point of view, is definitely vaccination. Influenza vaccination is the most important part of the anti-epidemic as well anti-pandemic measures (4) . Influenza vaccination has a good legislative support in SR, and health insurance companies fully reimburse for the influenza vaccination in accordance with recommendation by public health authorities. In spite of these facts, vaccination coverage is still very low.
MaTeRiaLs anD MeThODs
Until 2006, data were obtained from the Information System of Hygiene, Epidemiology and Microbiology (ISHEM) program. Since 2006, relevant data has been collected from the "Influenza" program was implemented, which is a part of the Epidemiological Information System (EPIS), available through a web portal also to the reporting physicians.
In the SR ARI/ILI are monitored and reported all year round. Influenza in the areas with a temperate climate, where also the SR belongs, occurs in the winter months from the 40th calendar week (CW) of the actual year until the 18th CW of the following year. This period is referred to as the "Influenza season". Until the 2005/2006 influenza season, all newly detected cases of ARI/ ILI had to be reported together. The calculation of morbidity was done for 100,000 inhabitants. As of the 2006/2007 season, the ARI/ILI have been reported separately in the SR in accordance with the monitoring requirements set by the EISS project, and the morbidity calculation is based on the number of persons who are registered with the reporting physicians:
-ARI -any acute infection of the respiratory system with or without fever such as: cold, rhinopharyngitis, tonsillitis, sinusitis, otitis media, laryngitis, tracheitis, bronchitis, bronchiolitis, pneumonia and bronchopneumonia.
-ILI -an illness with a sudden onset, fever, with a presence of at least one of the overall symptoms, such as headache, myalgia, arthralgia, chills and with a presence of at least one of the respiratory symptoms, such as cough, sore throat, cold.
Reports on occurrence are sent by the general practitioners for adults (GP) and paediatricians according to a prescribed model on a weekly basis all year round to a respective Regional Public Health Authority (RPHA). During a mass outbreak, a time interval of reporting is set by RPHA. The reporting is done by phone, fax or e-mail. Reports include number of new cases reported in the period of 7 days starting on Friday and ending on Thursday of the following week. They are marked with a calendar week, in which the collection is completed.
The weekly reports are submitted to the respective RPHA which should receive them on Friday by 8 a.m. at latest. The reports are gradually processed and analyzed at the district, regional and national levels. Then they are sent to the EISS.
Monitoring of the age-specific incidence and complication incidence is done in five age groups: -0-5 years old, pre-school children - [6] [7] [8] [9] [10] [11] [12] [13] [14] When assessing the epidemiological situation, also data on the number of patients treated with ARI/ILI by first aid services and data on ratio of children's school absence are used. If more than 30% of the collective members were absent due to the ARI/ILI, the situation is assessed as an epidemic.
With respect to an epidemic occurence, the following criteria are applied regarding the size of the affected area:
Local epidemic -a double increase in morbidity in town or village during two consecutive weeks, or if there are the epidemics in the collectives attended by more than 50% of the town/village's inhabitants; laboratory detection of influenza virus circulation.
District epidemic -a double increase in morbidity in the district's territory during two consecutive weeks, or if there are the local epidemics in the territory, where more than 50% of the district's inhabitants live; laboratory detection of influenza virus circulation.
Regional epidemic -a double increase in morbidity in the region's territory during two consecutive weeks, or if there are the district epidemics in the territory, where more than 50% of the region's population live; laboratory detection of influenza virus circulation.
National epidemic -a double increase in morbidity in the whole SR during two consecutive weeks, or if there are the regional epidemics in the territory, where more than 50% of the SR population live; laboratory detection of influenza virus circulation.
Besides surveillance of morbidity, mortality, complications with ARI/ILI, there is sentinel surveillance of influenza virus circulation in the population implemented in every county. The selected sentinel physicians, approximately 1-2 paediatricians and 1-2 GPs for adults regularly take nasopharyngeal swabs from patients with suspected influenza and send them to a laboratory.
Nasopharyngeal swabs are collected and placed into containers with viral transport medium -(Medium 199 with 0.5% BSA and antibiotics Penicillin G, streptomycin, amphotericin, gentamicin) supplied by the laboratory (5, 6). To confirm the diseases, direct or indirect laboratory diagnosis is used. Direct diagnosis includes:
1. An attempt to isolate influenza viruses in MDCK cell cultures (2-6 days) and in 10-day-old chicken embryos (10-20 days).
2. A direct detection of influenza virus antigens by the ELISA method (detection in 24 hours). From 2005, the methods under 1 and 2 were not used any longer in the SR.
3. Direct detection of influenza virus antigens by a rapid screening method (within 20 minutes). This test is intended for an informative mostly outpatient use.
4. Molecular biological test -the polymerase chain reaction (PCR) and Real-time PCR (result in a few hours) (7) .
Indirect diagnosis -retrospective serological examination is done by a complement fixation reaction and hemagglutinationinhibition reaction. The examination result is assessed using antibody titre levels from two blood samples of a patient. The first sample is taken in an acute phase, followed by the second one in 2-3 weeks. Only the significant increase in antibody titre determines a positive result (8, 9) . The examinations are carried out in 3 virological laboratories in the SR, namely in the laboratory of NRC for influenza in Bratislava and in the laboratories of the RPHA Košice and Banská Bystrica. Further identification of the isolated influenza virus strains is carried out in the NRC, which at the same time cooperates with the WHO international laboratory in London (10) . Here they confirm the results of identification done in the NRC. The laboratory results from the above laboratories are reported to the NRC once a week during the influenza season, and once a month out of the season.
Vaccination Morbidity below 30,000 cases/100,000 inhabitants was reported in 8 calendar years. Morbidity per year ranged most frequently from 30,000-40,000 cases per 100,000 inhabitants (Fig. 1) . ARI/ILI morbidity curves used to have at the beginning of the season towards the end of the calendar year almost identical developments with a gradual increase and decrease during the Christmas season. This phenomenon was observed practically every year except for the year 1995, when the epidemic culminated in 51st calendar week with morbidity of 6,159.8/100,000, so just before the Christmas season. However, early in the following year, a gradual increase in morbidity can be seen. In recent years, the increase ARI/ILI morbidity was reported several times during the season, i.e., one before Christmas and second one in February or March.
From 1993 to 2008, the epidemics were reported 2 times in December, 1 time in January, 9 times in February (56%) and 4 times in March. They lasted 4-9 weeks, 5.8 weeks on average. The highest morbidity per week and outbreak ranged from 1,065.8/100,000 in 2006 to 6,159.8/100,000 in 1995. Morbidity reached over 2,000/100,000 inhabitants in 10 from 16 monitored years (Table 1 Most complications were reported in the years 1997-1999, which corresponds with the highest number of diseases reported during these years (Fig. 2) . As of 2007, the attention has been paid to the following major diagnosis only: bronchopneumonia and pneumonia, sinusitis and otitis. To isolate influenza virus, the materials were collected from the diseased subjects during the monitored years. As of 2003, when the SR was integrated into the sentinel system of influenza reporting, an increase in the number of examined biological material and thus also in influenza virus isolations can be observed. Before the implementation of the sentinel in 1993-2002, the number of isolations was 0-45 per season. After the implementation, the number of influenza virus isolation ranged from 109 to 260 (Fig. 3) .
Season
For an attempt to isolate influenza virus, the nasopharyngeal swabs were taken every year. They were taken from the outset of the season. Their number gradually increased in connection with increasing morbidity. 1979  1980  1981  1982  1983  1984  1985  1986  1987  1988  1989  1990  1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006 From 1993 to 1998, influenza vaccination coverage was minimal in SR, it ranged from 1-3% of the overall population (about 50,000 up to 150,000 persons). Only in 1999 some health insurance companies decided to buy the influenza vaccines for a group of people at risk of influenza infection, which increased vaccination coverage to 4.9%. As of 2000, all health insurance companies (HIC) have begun to reimburse the influenza vaccines to groups of people at risk. The groups of people to whom the HIC fully reimburse influenza vaccines are annually extended. The reimbursement by the health insurance companies is set by the indicative limits of the Ministry of Health of the SR. The HIC currently reimburse influenza vaccines to all children from 6 months to 12 years of age and to all persons aged 59 years and older. Furhter, to all persons irrespective of age with serious chronic respiratory diseases, cardiovascular diseases, metabolic, renal and immune disorders. Vaccination is compulsory for the persons living in social service facilities and is underpinned by legislation for all healthcare workers and people working in the areas with a risk of infection. In 2007 and 2008, the HIC fully reimbursed influenza vaccination to the general population. Even despite the existing legislation and good will of the HIC that are fully aware of the health and economic importance of influenza vaccination, influenza vaccination coverage is still very low in SR.
It stagnates in the last 3 years and objectively it did exceed 10% (Fig. 4) . The groups of people with the lowest vaccination coverage are children under 15 years of age -4% and persons aged 16 to 59 years -7%. The highest vaccination coverage is in the group of persons aged 60 years and older -32%. These alarming numbers are caused on the one hand mainly by low awareness of citizens who do not know about this possibility of protection, because of their insufficient information, and on the other hand, it is lack of interest on the part of the GPs and the anti-vaccination, non-expert media performances. Vaccination coverage of SR population is below the limits recommended by WHO experts.
DisCUssiOn
Influenza is an infection that accompanies the humankind for a very long time, it is constantly present in the population and it is the most frequent human disease. It occurs annually with a greater or lesser strength, in the form of the epidemics or pandemics. It causes high morbidity and the enormous health and economic damages. In 1933, Sir Christopher Andrewes isolated with his colleagues an influenza virus (4) . Further study of the virus revealed a connection of the epidemics with the virus variability. A definition of influenza epidemic is very complex. The general rule is that the epidemic occurs, if the number of disease cases exceeds the expected numbers. Individual countries have different criteria for a definition of influenza epidemic. In the SR, influenza epidemic is announced according to the incidence rates based on a weekly ARI/ILI monitoring. ILI are recorded mainly in January (10) .
The influenza epidemic is announced, if a double increase in morbidity is observed during two consecutive weeks or if the disease spreads over the territory, where more than 50% of the population live in. In the Czech Republic (CR) it is announced, if the ARI/ILI incidence is higher than 2,000 cases/100,000 inhabitants (11) . In England they monitor the number of the persons examined due to ARI/ILI. If the number of ARI/ILI patients reaches 400/100,000 of all health services contacts, the epidemic spread is considered. In the US, influenza activity is monitored on the basis of the surveillance of influenza-associated deaths and the associated pneumonias. However, there have not been any typical winter epidemics recorded in SR in recent years (12) . The influenza epidemics occur in the countries with a temperate climate in 1-3 year cycles (13) . It can be seen in the present analysis that the epidemic outbreaks occur at irregular time intervals. During the period 1993 to 2000 there were 7 outbreaks and from 2001 to 2008 only three outbreaks reported. Even though the influenza affects annually about 10% of the world's population, it is still underestimated to a great extent and perceived by expert and general public as a trivial and benign disease. Between the years 1979-2008, ARI/ILI affected from 1,018,692 to 2,527,662 persons, which is about 18-45% of the overall SR population. Most diseases were reported during the epidemic. The number of ARI/ILI in the epidemics ranged from 259,247 in 2006 to 934,086 in 1999, 4.7-17.0% of the overall population. Havlík states that during an epidemic, 10-20% of the population may be affected (11) . Despite the ever expanding range of scientific knowledge on influenza, we are still unable to stop its epidemic spread. Declining role of national borders calls for a coordinated approach to surveillance of ARI/ILI (14, 15, 16) . Many authors state that actual influenza morbidity and mortality recorded during epidemics is in fact much higher than that reported officially. Mostly affected are the so called risk groups. These are mainly the elderly or persons with primary chronic disease (e.g. chronic respiratory, cardiovascular or metabolic disease). At the same time, the persons older than 65 years have significantly weakened immune protection against influenza infection. In these persons, the serious complications occur more frequently and very often lead to death. In our analysis, from 55 death cases, 45% of persons were older than 60 years. The other risk group consists of small children, mainly at the age of 0-5. These children are in general most affected by morbidity every year during the influenza season.
The influenza epidemics hit the SR annually from December to March, mostly with its peak at the end of February. The largest epidemic was reported in December 1995 with the incidence reaching its peak of 6,159.8 cases/100,000. Laboratory detection of influenza illnesses is one of the major problems in the confirmation of influenza illnesses and subsequent adoption of anti-epidemic measures. The clinical symptoms of influenza do not have to be distinct. Majority of patients treat themselves at home. They do not consult the GPs. And even if the patient visits the GP, material for laboratory confirmation of diagnosis is taken only exceptionally. More frequently the GPs are consulted by the patients already suffering from bacterial infections. In recovery, however, the tests on direct virus detection (isolation, antigen detection, PCR) are already negative.
During the monitored years, the epidemics have been caused in turns by the H3N2 and H1N1 subtypes. From 1993 to 2000, only the H3N2 subtype was isolated also in Europe (8) .
From 2001 to 2008, both subtypes circulated and alternated with influenza virus B (17) . These strains have circulated also in the CR (7). The year 2003 is an exception, when the rarely circulating new H1N2 subtype was isolated. It suggests that influenza surveillance in the SR is well performed. The results show the need for sustained and organized influenza surveillance.
The only way of prevention is vaccination. Vaccination may protect not only the persons mostly endangered with a complicated course of the disease, but also the healthy persons, because if they become ill, their incapacity to work would lead to great economic losses. Attainable vaccination coverage is also illeffected, for instance, by the interventions of our physicians, who appear in popular media with unverified and unconfirmed anti-vaccination statements as happened for example in 2002. This had subsequently a profound negative impact on vaccination coverage, which decreased to 3.5% and affected the vaccination morale in the following years as well. The groups of people with the lowest vaccination coverage are children under 15 years of age and persons aged 16 to 59 years. SR markedly falls in influenza vaccination behind the developed countries of the world and EU countries, where vaccination coverage of the overall population is about 30% and that of the risk population reaches even 70 up to 90%. We have been therefore promted to assume a responsible approach in order not only to protect the SR population, but also prevent transmission within EU countries.
The HIC fully reimburse all influenza vaccines required for protection of the population at risk with respect restriction set up by public health authorities of SR. (18) . Medical market is sufficiently supplied with influenza vaccines suitable for all ages. morbidity separately and calculate the morbidity per number of persons registered with GP in question -Vaccination uptake is stagnating, coverage not exceeding the level of 10% due to the low awareness of citizens, lack of interest in influenza prevention by GPs and incongruous media statesments with regards to vaccination.
